Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?

Diabetes and Metabolism

Volumn 41, Issue 5, 2015, Pages 393-400

  Honnorat, D ^a   Disse, E ^a,b   Millot, L ^c   Mathiotte, E ^b,d   Claret, M ^a   Charrie, A ^a,b   Drai, J ^a   Garnier, L ^a   Maurice, C ^d   Durand, E ^d   Simon, C ^a,b   Dupuis, O ^a   Thivolet, C ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

^c North Hospital   (France)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

Adipokines; Cytokines; Gestational diabetes; Metabolic syndrome; Screening

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY MASS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PARITY; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN; BLOOD; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FRANCE; INSULIN RESISTANCE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; PUERPERIUM; SEVERITY OF ILLNESS INDEX;

ADIPONECTIN; BIOMARKERS; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FRANCE; HUMANS; INSULIN RESISTANCE; LEPTIN; OVERWEIGHT; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84947039068     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.03.003     Document Type: Article

References (34)

1. Langer O., Mazze R. The relationship between large-for-gestational-age infants and glycaemic control in women with gestational diabetes. Am J Obstet Gynecol 1988, 159:1478-1483.
2. Hyperglycaemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002. The HAPO Study Cooperative Research Group.
3. Metzger B.E., Gabbe S.G., Persson B., Persson B. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycaemia in pregnancy. Diabetes Care 2010, 33:676-682. International Association of Diabetes Pregnancy Study Groups Consensus Panel.
4. Mission JF1, Ohno M.S., Cheng Y.W., Caughey A.B. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 2012, 207:326e1-326e9.
5. Vandorsten JP1, Dodson W.C., Espeland M.A., Grobman W.A., Guise J.M., Mercer B.M., et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements 2013, 29:1-31.
6. Doherty D.A., Magann E.F., Francis J., Morrison J.C., Newnham J.P. Prepregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 2006, 95:242-247.
7. Kim S.Y., Sharma A.J., Sappenfield W., Wilson H.G., Salihu H.M. Association of maternal body mass index, excessive weight gain, and gestational diabetes mellitus with large-for-gestational-age births. Obstet Gynecol 2014, 123:737-744.
8. Chodick G., Elchalal U., Sella T., Heymann A.D., Porath A., Kokia E., et al. The risk of overt diabetes mellitus among women with gestational diabetes: a population-based study. Diabet Med 2010, 27:779-785.
9. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
10. Disse E., Graeppi-Dulac J., Joncour-Mills G., Dupuis O., Thivolet C. Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus. Diabetes Metab 2013, 39:132-138.
11. McAuley K.A., Williams S.M., Mann J.I., Walker R.J., Lewis-Barned N.J., Temple L.A., et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001, 24:460-464.
12. Hadar E., Hod M. Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Ann N Y Acad Sci 2010, 1205:88-93.
13. Ryan E.A. Diagnosing gestational diabetes. Diabetologia 2011, 54:480-486.
14. McIntyre H.D. Diagnosing gestational diabetes mellitus: rationed or rationally related to risk?. Diabetes Care 2013, 36:2879-2880.
15. Catalano P.M., McIntyre H.D., Cruickshank J.K., McCance D.R., Dyer A.R., Metzger B.E., et al. HAPO Study Cooperative Research Group. The hyperglycaemia and adverse pregnancy outcome study; associations of GDM and obesity with pregnancy outcomes. Diabetes Care 2012, 35:780-786.
16. Kalter-Leibovici O., Freedman L.S., Olmer L., Liebermann N., Heymann A., Tal O., et al. Screening and diagnosis of gestational diabetes mellitus: critical appraisal of the new International Association of Diabetes in Pregnancy Study Group recommendations on a national level. Diabetes Care 2012, 35:1894-1896.
17. Liu J., Leng J., Tang C., Liu G., Hay J., Wang J., et al. Maternal glucose level and body mass index measured at gestational diabetes mellitus screening and the risk of macrosomia: results from a perinatal cohort study. BMJ Open 2014, 4:e004538.
18. Maple-Brown L., Ye C., Hanley A.J., Connelly P.W., Sermer M., Zinman B., et al. Maternal pregravid weight is the primary determinant of serum leptin and its metabolic associations in pregnancy, irrespective of gestational glucose tolerance status. J Clin Endocrinol Metab 2012, 97:4148-4155.
19. Avalos G.E., Owens L.A., Dunne F. Applying current screening tools for gestational diabetes mellitus to a European population: is it time for change?. Diabetes Care 2013, 36:3040-3044. ATLANTIC DIP Collaborators.
20. Pallardo F., Herranz L., Garcia-Ingelmo T., Grande C., Martin-Vaquero P., Jañez M., et al. Postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999, 22:1053-1058.
21. Kramer C.K., Swaminathan B., Hanley A.J., Connelly P.W., Sermer M., Zinman B., et al. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of β-cell function, insulin sensitivity, and glycaemia in the first 3 years postpartum. Diabetes Care 2014 D, 37:3262-3269.
22. Catalano P.M., Vargo K.M., Bernstein I.M., Amini S.B. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991, 165:914-919.
23. Sivan E., Chen X., Homko C.J., Reece E.A., Boden G. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 1997, 20:1470-1475.
24. Kirwan J.P., Huston-Presley L., Kalhan S.C., Catalano P.M. Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 2001, 24:1602-1607.
25. Ategbo J.M., Grissa O., Yessoufou A., Hichami A., Dramane K.L., Moutairou K., et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006, 91:4137-4143.
26. Williams M.A., Qiu C., Muy-Rivera M., Vadachkoria S., Song T., Luthy D.A. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab 2004, 89:2306-2311.
27. Kuzmicki M., Telejko B., Zonenberg A., Szamatowicz J., Kretowski A., Nikolajuk A., et al. Circulating pro- and anti-inflammatory cytokines in Polish women with gestational diabetes. Horm Metab Res 2008, 40:556-560.
28. Gomes C.P., Torloni M.R., Gueuvoghlanian-Silva B.Y., Alexandre S.M., Mattar R., Daher S. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol 2013, 69:545-557.
29. Lacroix M1, Battista M.C., Doyon M., Ménard J., Ardilouze J.L., Perron P., et al. Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 2013, 36:1577-1583.
30. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302:179-188.
31. Winzer C., Wagner O., Festa A., Schneider B., Roden M., Bancher-Todesca D., et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 2004, 27:1721-1727.
32. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Hanley A.J., Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010, 53:268-276.
33. Kirwan JP1, Hauguel-De Mouzon S., Lepercq J., Challier J.C., Huston-Presley L., Friedman J.E., et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
34. Magee T.R., Ross M.G., Wedekind L., Desai M., Kjos S., Belkacemi L. Gestational diabetes mellitus alters apoptotic and inflammatory gene expression of trophobasts from human term placenta. J Diabetes Complications 2014, 28:448-459.